ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,626.02
      0.54%
      US Tech 100
      18,986.40
      0.30%
      Dow Jones
      41,393.78
      0.72%
      Brent Oil
      71.825
      0.00%
      Bitcoin
      60,056.54
      -0.86%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. Emergent Biosolutions Inc (EBS) Quote

      Emergent Biosolutions Inc

      Emergent Biosolutions Inc (EBS)

      NYSE
      7.87
      0.24
      (3.15%)
      Closed September 14 4:00PM
      Delayed by 15 minutes
      7.89
      0.02
      (0.25%)
      After Hours: 7:45PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      7.89
      Bid
      -
      Ask
      -
      Volume
      1,518,285
      7.51 Day's Range 8.185
      1.42 52 Week Range 58.33
      Market Cap
      417.433M
      Previous Close
      7.63
      Open
      7.51
      Last Trade
      1
      @
      7.8
      Last Trade Time
      Financial Volume
      $ 12,023,012
      VWAP
      7.9188
      Average Volume (3m)
      3,808,113
      Shares Outstanding
      52,906,624
      Dividend Yield
      -
      PE Ratio
      -0.55
      Earnings Per Share (EPS)
      -14.37
      Revenue
      1.05B
      Net Profit
      -760.5M

      About Emergent Biosolutions Inc

      Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based... Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.emergentbiosolutions.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Emergent Biosolutions Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker EBS. The last closing price for Emergent Biosolutions was $7.63. Over the last year, Emergent Biosolutions shares have traded in a share price range of $ 1.42 to $ 58.33.

      Emergent Biosolutions currently has 52,906,624 shares outstanding. The market capitalization of Emergent Biosolutions is $403.68 million. Emergent Biosolutions has a price to earnings ratio (PE ratio) of -0.55.

      Ask ADVFN Intelligence (AI)

      EBS Latest News

      More News

      Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation

      GAITHERSBURG, Md., Sept. 13, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) (“Emergent” or the “Company”) today announced that it has entered into an agreement to resolve the...

      September 13 2024
      GlobeNewswire Inc.

      Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

      GAITHERSBURG, Md., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a contract modification executing an option period by...

      September 12 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      September 03 2024
      Edgar (US Regulatory)

      Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile

      GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) --  Emergent BioSolutions Inc. (NYSE: EBS) today announced the closing of a new credit facility agreement with Oak Hill Advisors for a term...

      September 03 2024
      GlobeNewswire Inc.

      Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness

      For the second year, Emergent is teaming up with pro football legend, Emmitt Smith, to educate communities on opioid risks and how to be prepared with NARCAN® Nasal SprayIn recognition of...

      August 30 2024
      GlobeNewswire Inc.

      Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions

      GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental...

      August 29 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      August 20 2024
      Edgar (US Regulatory)

      Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals

      GAITHERSBURG, Md., Aug. 20, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has completed the sale of its drug product facility in Baltimore-Camden to an...

      August 20 2024
      GlobeNewswire Inc.

      Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa

      Active engagement with the World Health Organization, U.S. government and other global health leaders on critical efforts to prevent mpox disease transmission50,000 doses of ACAM2000®, (Smallpox...

      August 19 2024
      GlobeNewswire Inc.

      Emergent BioSolutions Reports Second Quarter 2024 Financial Results

      Second Quarter 2024 Total Revenues of $254.7 million, above the prior guidance rangeSecond Quarter 2024 Net Loss of $283.1 million and Adjusted EBITDA of $(10.1) millionUpdates FY 2024 guidance...

      August 06 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-2.11-21.11013.27537.1136327829.63754238CS
      41.3520.64220183496.5415.15.2531362689.5250946CS
      125.54235.7446808512.3515.11.820138081135.90730163CS
      263.7590.57971014494.1415.11.4231000944.6569108CS
      52-49.82-86.328192687657.7158.331.42176558610.78591776CS
      156-46.52-85.498989156454.41137.611.42129697323.60316665CS
      2600008.185000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AZULAzul SA
      $ 2.77
      (32.54%)
      		10.77M
      RHRH
      $ 321.87
      (25.49%)
      		4.53M
      DNMRDanimer Scientific Inc
      $ 0.395
      (19.70%)
      		1.64M
      LDIloanDepot Inc
      $ 2.675
      (17.32%)
      		1.29M
      RMAXRE MAX Holdings Inc
      $ 12.915
      (17.30%)
      		621.8k
      SLQTSelectQuote Inc
      $ 2.02
      (-43.73%)
      		12.87M
      KUKEKuke Music Holding Limited
      $ 0.63
      (-34.38%)
      		1.36M
      STGSunlands Technology Group
      $ 4.95
      (-29.59%)
      		60.9k
      LITBLightInTheBox Holding Co Ltd
      $ 3.72
      (-19.13%)
      		31.79k
      AKAaka Brands Holding Corp
      $ 25.53
      (-16.30%)
      		23.65k
      NIONIO Inc
      $ 5.535
      (4.83%)
      		64.04M
      PLTRPalantir Technologies Inc
      $ 35.59
      (1.95%)
      		49.28M
      MPWMedical Properties Trust Inc
      $ 6.37
      (13.75%)
      		36.53M
      FFord Motor Company
      $ 10.68
      (0.56%)
      		35.08M
      BBDBanco Bradesco SA
      $ 2.79
      (0.36%)
      		34.31M

      EBS Discussion

      View Posts
      Monksdream Monksdream 1 week ago
      EBS chart
      👍️0
      eyeownu eyeownu 1 week ago
      added more this will be in double digits in no time. alllllllllllll aboard.
      👍️0
      allenc allenc 2 weeks ago
      Expect we see a contract for the vaccine soon. $200M in debt reduction, anticipating increase sales of Narcan, this should be a booming Q4 IMO.
      👍️ 1
      Biggiee Biggiee 2 weeks ago
      https://www.unicef.org/press-releases/unicef-issues-emergency-tender-secure-mpox-vaccines-crisis-hit-countries
      👍️0
      eyeownu eyeownu 2 weeks ago
      bought 2500 shares today
      👍️0
      Biggiee Biggiee 2 weeks ago
      Nasty bull trap with that FDA news ah yesterday, but should snap back to double digits when the dark overlords are done playing
      👍️0
      81vette 81vette 2 weeks ago
      Tutes own 58%,short 3.5m(covering coming)shares to short dropping now,fee rising and rebate dropping,tutes want their shares back before it runs up,patience required on my part isn’t easy lol.
      👍️0
      Biggiee Biggiee 2 weeks ago
      Loading up now, see you next week!
      GLTA
      👍️0
      Roadtojourney Roadtojourney 2 weeks ago
      What a pos seems like approval was already priced in?? Sell on news??
      👍️0
      Biggiee Biggiee 2 weeks ago
      FDA approval for MPOX
      👍️0
      Biggiee Biggiee 3 weeks ago
      $EBS Rodman & Renshaw initiated coverage of Emergent Biosolutions (NYSE: EBS) with a price target of $16.
      👍️0
      LEFTY1182 LEFTY1182 3 weeks ago
      Soon enough people will catch on with the monkey pox coming! $200+ coming here imo
      👍️0
      Biggiee Biggiee 3 weeks ago
      Why do I bother messaging this board? Talking to myself! Goodnight!
      👍️0
      Biggiee Biggiee 3 weeks ago
      It’s go time once more!
      👍️0
      Biggiee Biggiee 3 weeks ago
      Selling my 9’s here @10.10. Quick flip, I think she goes lower.
      GLTA
      👍️0
      Biggiee Biggiee 4 weeks ago
      Sold yesterday, looking for a pullback now to $9’s. Media hasn’t latched on to the crisis fear just yet, we shall see
      $EBS
      👍️0
      81vette 81vette 4 weeks ago
      Shares to short dropping,getting excited as word is spreading faster than the virus lol
      👍️0
      81vette 81vette 4 weeks ago
      3.6m short,could squeeze big after hrs
      👍️0
      Biggiee Biggiee 4 weeks ago
      The coming news cycle of “fear the mpox” will do more than just pop. I see a sustained rising trend from here on out. Start looking at the weekly and monthly charts instead of the daily.
      $EBS
      👍️0
      EnchantedTitan62 EnchantedTitan62 4 weeks ago
      If they get FDA approval which they are now seeking, it will surely pop again.
      👍️0
      Biggiee Biggiee 1 month ago
      It’s go time again, monkey biz
      👍️0
      Biggiee Biggiee 1 month ago
      Yikes! Smoldering crater
      👍️0
      Biggiee Biggiee 1 month ago
      Todays the day! Place your bets for AH
      GLtA
      👍️0
      Biggiee Biggiee 1 month ago
      Tree shake! Earnings coming on Aug 6 AH
      One to watch $EBS
      👍️0
      Biggiee Biggiee 2 months ago
      Feels like it could be a buy out. Market cap isn’t even a billy, and we are talking about NARCAN! Any guesses above these prices seems like a good bet
      👍️0
      Sirpeter Sirpeter 2 months ago
      How high do you see this going
      👍️0
      Biggiee Biggiee 2 months ago
      F’in beast! $14!
      👍️0
      Biggiee Biggiee 2 months ago
      $13 hit. Such a beast!
      👍️0
      Biggiee Biggiee 2 months ago
      Jumped back in $12.01, I think it’s time to challenge $13
      👍️0
      Biggiee Biggiee 2 months ago
      Looking for the right time to get back in here. $EBS
      👍️0
      EnchantedTitan62 EnchantedTitan62 2 months ago
      Thanks, left some on the table too. I see youve been here for awhile so I'm ' following' ya for any good plays. My picks tend to be long term . Good day sir.
      👍️0
      Biggiee Biggiee 2 months ago
      Nice! Cheers!
      👍️0
      EnchantedTitan62 EnchantedTitan62 2 months ago
      Sold 175 @ 12.05 for $7 gain/share. Not enough to buy a beach house in Cape Cod, but I can buy a plane ticket ! Ha.
      👍️0
      Biggiee Biggiee 2 months ago
      Out 12.20, will jump back in once they finish shaking the tree. Thanks!
      👍️0
      Biggiee Biggiee 2 months ago
      lol, life goes on
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      EBS...TOP IS IN
      👍️0
      EnchantedTitan62 EnchantedTitan62 2 months ago
      Taking a break from chopping wood for the winter. Looks like another day IN THE GREEN. 💲
      👍️0
      Biggiee Biggiee 2 months ago
      Makes sense. The big shorts are leaving the small fries to burn?
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      THE SHORT YESTERDAY WAS ONLY 350 000 AND SHORT COVERING WAS 850 000....IT WAS INTENDED TO LOWER PPS TO COVER
      👍️0
      Biggiee Biggiee 2 months ago
      Short attack failed, see you on the moon
      $EBS
      👍️0
      TrendTrade2016 TrendTrade2016 2 months ago
      EBS...HEADED TO MONTHLY TOP BAND
      👍️0
      EnchantedTitan62 EnchantedTitan62 2 months ago
      Up again premarket. Well this retired guy has stuff to do today. Will check on this beautiful 💰💰💰 making machine later today.
      👍️0
      ANTADOG ANTADOG 2 months ago
      12,82 pm, looks like someone nailed it again, yup, ANT
      👍️0
      EnchantedTitan62 EnchantedTitan62 2 months ago
      According to SEC documents, Blackrock as of June 7 2024 still owns over 6,600,000 shares of EBS. Uh, I'm going to continue to hold, they know more than us mere mortals .
      👍️0
      EnchantedTitan62 EnchantedTitan62 2 months ago
      As of March 30th 2024 guess what institution owned the most shares? Ok, got your guess? It's Blackrock with over 7 million shares.
      👍️0
      EnchantedTitan62 EnchantedTitan62 2 months ago
      According to Fintel, 10percent of float is shorted compared to 18percent 3 weeks ago
      👍️0
      EnchantedTitan62 EnchantedTitan62 2 months ago
      🤠👍👍👍
      👍️0
      luckydude777 luckydude777 2 months ago
      Looks to be a better short than long.
      👍️0
      kindo kindo 2 months ago
      Very nice!
      👍️0
      kindo kindo 2 months ago
      Very nice!
      👍️0

      Your Recent History

      NYSE
      EBS
      Emergent Biosolutions
      Delayed Upgrade Clock